Tabula Rasa HealthCare, Inc. (TRHC)
| Market Cap | 168.17M |
| Revenue (ttm) | 302.49M |
| Net Income (ttm) | -139.24M |
| Shares Out | 27.12M |
| EPS (ttm) | -5.81 |
| PE Ratio | n/a |
| Forward PE | 217.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 77,661 |
| Open | 5.88 |
| Previous Close | 5.90 |
| Day's Range | 5.66 - 6.21 |
| 52-Week Range | 2.09 - 10.34 |
| Beta | 1.52 |
| Analysts | Buy |
| Price Target | 6.04 (-2.58%) |
| Earnings Date | Feb 23, 2023 |
About TRHC
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic he... [Read more]
Financial Performance
In 2021, TRHC's revenue was $331.26 million, an increase of 11.45% compared to the previous year's $297.22 million. Losses were -$79.06 million, -2.36% less than in 2020.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for TRHC stock is "Buy." The 12-month stock price forecast is $6.04, which is a decrease of -2.58% from the latest price.
News
Newsweek Names Tabula Rasa HealthCare Among America's Greatest Workplaces for Diversity
MOORESTOWN, N.J. , Jan. 19, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, was named among Ame...
Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations
Reports Preliminary Estimated Revenue from Continuing Operations of $82.0 - $83.0 Million for the Fourth Quarter of 2022, Continuing Strong 2022 Revenue Performance as Company Focuses on Core Business...
Center for Elders' Independence Signs with TRHC for Key PACE Services
Agreement with one of the nation's largest PACE programs underscores TRHC's momentum delivering PACE-specific products and services into this crucial market MOORESTOWN, N.J. , Nov. 8, 2022 /PRNewswir...
Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Tops Revenue Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -1,366.67% and 4.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...
Tabula Rasa HealthCare Reports Third Quarter 2022 Results
Revenue from continuing operations of $77.1 million increased 14% vs. a year ago GAAP net loss from continuing operations of $25.9 million vs.
Tabula Rasa HealthCare Names April Gill Chief Commercial Officer
MOORESTOWN, N.J. , Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the ...
Tabula Rasa HealthCare Named a 2022 Champion of Board Diversity
MOORESTOWN, N.J. , Oct. 26, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, was named a Champio...
Tabula Rasa HealthCare Schedules Third Quarter 2022 Earnings Conference Call
MOORESTOWN, N.J. , Oct. 20, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC), will hold a conference call and webcast to discuss its third quarter 2022 operating results Friday, Novemb...
TRHC Adds Ron Mitchell to its Board of Directors
Ron Mitchell, Co-Founder and CEO of Humanity Health, joins Board of Directors MOORESTOWN, N.J. , Oct. 11, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthc...
TRHC's Clinical Advisory Panel Meeting Provides Insights on PACE Pharmacy
MOORESTOWN, N.J. , Sept. 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, hosted its 2022 C...
IRobot and Tabula Rasa See Activist Action
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
Tabula Rasa HealthCare Announces Cooperation Agreement with Indaba Capital Management to Refresh the Company's Leadership and Board of Directors
Agreement Also Provides for Enhancements to the Company's Corporate Governance, Including a Commitment to Propose a De-Classification of the Board at the 2023 Annual Meeting MOORESTOWN, N.J. , Sept. 1...
Tabula Rasa HealthCare Announces Leadership Transition
Drs. Calvin H. Knowlton and Orsula V.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Tabula Rasa Healthcare (TRHC)
Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several...
New Study Demonstrates Benefit of Advanced Decision Support in Driving Pharmacist Recommendations to Reduce Medication Risk
Medication decision support helps identify potentially inappropriate medication MOORESTOWN, N.J. , Aug. 16, 2022 /PRNewswire/ -- A new peer-reviewed study from Tabula Rasa HealthCare, Inc.® (TRHC) (NA...
Indaba Issues Letter to Tabula Rasa's Independent Directors Regarding Their Apparent Prioritization of the Knowltons' Interests Over Shareholders' Interests
SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management L.P. (together with its affiliates, “Indaba” or “we”), which is the largest shareholder of Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) (“Tabula...
Does Tabula Rasa Healthcare (TRHC) Have the Potential to Rally 80% as Wall Street Analysts Expect?
The mean of analysts' price targets for Tabula Rasa Healthcare (TRHC) points to a 79.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...
Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Tabula Rasa HealthCare Reports Second Quarter 2022 Results
Revenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%.
Here's Why Tabula Rasa Healthcare (TRHC) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Tabula Rasa Healthcare (TRHC), indicating that the stock has found support. This, combined with an upward trend in earnings e...
Transaction Data Systems Completes Acquisition of PrescribeWellness
ORLANDO, Fla.--(BUSINESS WIRE)--Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced the successful completion of its acquisition of PrescribeWellness from Tabula...
Tabula Rasa HealthCare Completes Sale of PrescribeWellness to Transaction Data Systems for $140 Million
MOORESTOWN, N.J. , Aug. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, a...
Tabula Rasa Healthcare (TRHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Indaba Capital Delivers Demand for Inspection of Books and Records of Tabula Rasa HealthCare, Pursuant to Section 220 of Delaware Law
SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management L.P. (together with its affiliates, “Indaba” or “we”), which is the largest shareholder of Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) (“Tabula...
Tabula Rasa HealthCare Announces Five-Year Contract Extension with Trinity Health PACE
MOORESTOWN, N.J. , July 27, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a f...